Optas LLC’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$723K Sell
1,784
-150
-8% -$60.8K 0.14% 92
2025
Q1
$962K Buy
1,934
+262
+16% +$130K 0.17% 66
2024
Q4
$870K Sell
1,672
-232
-12% -$121K 0.19% 66
2024
Q3
$1.18M Buy
1,904
+164
+9% +$101K 0.27% 53
2024
Q2
$962K Sell
1,740
-320
-16% -$177K 0.25% 53
2024
Q1
$1.2M Sell
2,060
-173
-8% -$101K 0.33% 48
2023
Q4
$1.19M Sell
2,233
-158
-7% -$83.9K 0.36% 46
2023
Q3
$1.21M Buy
2,391
+134
+6% +$67.8K 0.4% 43
2023
Q2
$1.18M Sell
2,257
-19
-0.8% -$9.91K 0.39% 45
2023
Q1
$1.31M Buy
2,276
+27
+1% +$15.6K 0.47% 43
2022
Q4
$1.24M Buy
2,249
+10
+0.4% +$5.51K 0.51% 36
2022
Q3
$1.14M Sell
2,239
-13
-0.6% -$6.6K 0.5% 37
2022
Q2
$1.23M Buy
2,252
+784
+53% +$426K 0.5% 35
2022
Q1
$868K Buy
1,468
+7
+0.5% +$4.14K 0.28% 56
2021
Q4
$976K Buy
1,461
+1
+0.1% +$668 0.28% 53
2021
Q3
$834K Buy
1,460
+140
+11% +$80K 0.24% 56
2021
Q2
$666K Buy
1,320
+17
+1% +$8.58K 0.19% 68
2021
Q1
$595K Buy
1,303
+14
+1% +$6.39K 0.19% 75
2020
Q4
$600K Sell
1,289
-415
-24% -$193K 0.19% 67
2020
Q3
$752K Buy
1,704
+408
+31% +$180K 0.23% 73
2020
Q2
$469K Buy
1,296
+299
+30% +$108K 0.19% 67
2020
Q1
$282K Buy
997
+22
+2% +$6.22K 0.14% 98
2019
Q4
$317K Buy
+975
New +$317K 0.12% 114